With Early-Cancer Detection Technology, Delfi Diagnostics Looks to Beat Out Guardant Health, Illumina’s Grail and Others

· · 1 min read

Illumina has deep pockets, Guardant Health has deep experience. But this company with a growing team in Palo Alto says it will be able to offer early-cancer detection for less.

Read the full article at: www.bizjournals.com


BM

BioBuzz Media

BioBuzz is a life science media and community organization connecting professionals, companies, and organizations across the Mid-Atlantic region.